$ALKT

Alkami (ALKT) Q1 2026 Earnings Call Transcript

Alkami (ALKT) reported strong Q1 2026 results with 29% revenue growth and $22.3 million in adjusted EBITDA, exceeding expectations. The company highlighted consistent Annual Recurring Revenue (ARR) expansion, robust adoption of its Digital Sales and Service Platform (DSSP), and a significant increase in long-term revenue commitments, alongside authorizing its first $100 million share buyback program. Management also discussed growth headwinds from declining termination fees and temporary margin pressures, while emphasizing the successful integration of its Mantle acquisition and active development of AI-powered platform capabilities.

Original reporting
The Motley Fool · Motley Fool Transcribing
Published Apr 29, 2026, 10:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 30, 2026, 7:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alkami (ALKT) Q1 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ALKTBullishMed
01

Why it matters

The positive earnings report supports a bullish outlook, but investors should remain cautious of sector-specific risks and short-term margin pressures.

02

Market read

The earnings report is highly relevant for investors in fintech and SaaS sectors, indicating sector strength and ALKT's market position.

03

What to watch

Possible short-term margin pressures from integration costs and market competition could temper gains.

Timing: immediate to short-term (next 1-3 months)

Background

Alkami's Q1 2026 earnings demonstrate strong growth and strategic progress, including platform adoption and share buyback, amidst some growth headwinds.

Company-level read

Ticker impact

$ALKTBullishHigh confidence
Context

Primary focus of the earnings report, indicating significant impact on ALKT stock.

Expected impact

Moderate upward movement expected in the short to medium term, contingent on sustained growth and successful integration of recent acquisitions.

Evidence & confidence

The robust financial performance, strategic initiatives, and management's optimistic outlook support a positive price trajectory. The bullish sentiment score (0.537) further reinforces this outlook.

Market effects

Positive sentiment for fintech and SaaS companies, indicating sector growth.

Limited regional impact; primarily affects US-based fintech sector.

Moderate; reflects broader fintech industry trends but limited direct global implications.

Counterpoint

Potential overexuberance; recent gains may be priced in, and sector rotation could lead to volatility.

Key entities

  • Alkami Technology, Inc.

    A provider of digital banking solutions for financial institutions.

  • Mantle Acquisition

    Recent acquisition aimed at expanding ALKT's platform capabilities.

Related articles

$ALKTHighAI 9/10

Alkami (ALKT) Q2 2026 Earnings Call Transcript

Alkami Technology (ALKT) reported Q2 2026 ARR of $511.7 million (+21% YoY) and total revenue of $129.8 million (+15.9% YoY). Non-GAAP gross margin was 63.0% and adjusted EBITDA was $19.4 million. Q3 revenue guidance is $132.7 million to $134.2 million; full-year 2026 revenue guidance is $528 million to $531 million. Bank clients under contract: 54.

$ALKTMed

ALKAMI TECHNOLOGY, INC. (ALKT): Results of Operations and Financial Condition

ALKAMI TECHNOLOGY, INC. (ALKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alkami Announces Second Quarter 2026 Financial Results PLANO, Texas, July 29, 2026 (PRNewswire) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami” or “the Company”), a digital sales and service platform provider for financial institutions in the U.S., today announce

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.

$WMTMedAI 8/10

Walmart to Build $1.3 Billion Fulfillment Center in Georgia

Walmart plans to build a $1.3 billion automated fulfillment center in Carnesville, Georgia, creating 1,000 jobs and expanding shipping capacity. The 1.5 million-square-foot facility is part of Walmart's strategy to meet evolving customer expectations for speed and convenience. Construction is expected to begin in late 2026.